Skip to main content
. Author manuscript; available in PMC: 2014 Sep 6.
Published in final edited form as: Stroke. 2013 Apr 2;44(6):1606–1608. doi: 10.1161/STROKEAHA.111.000709

Table 1.

Baseline Characteristics of FVP Subset

Baseline Stroke Presentation Characteristics Treated Nontreated P Value
FVP (CoW intact and MAP>65 mm Hg) % (n/N) 94.5% (86/91) 85.1% (86/101) 0.0562
Time from symptom onset to BL, h Mean±SD 7.7±2.7 8.1±3.0 0.2817
Time from symptom onset to Rz, h Mean±SD 8.2±2.6 8.4±2.8 0.5530
Baseline NIHSS Mean±SD 11.5±4.3 10.7±4.4 0.2737
Systolic blood pressure, mm Hg Mean±SD 155.6±22.9 157.3±25.9 0.6420
Diastolic blood pressure, mm Hg Mean±SD 83.5±16.4 86.2±16.9 0.2725
Glucose, mg/dL Mean±SD 136.9±51.9 128.5±38.9 0.2653
Temperature, °C Mean±SD 36.7±0.5 36.6±0.5 0.3882
Heart rate, bpm Mean±SD 82.1±16.4 78.4±17.4 0.1077
Respiratory rate Mean±SD 18.3±3.2 17.5±3.1 0.1395
Side of infarct (right) % (n/N) 45.1% (41/91) 55.4% (56/101) 0.1932

Baseline characteristics of the FVP subset of the Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke trial. BL indicates baseline; CoW, Circle of Willis; FVP, favorable vascular profile; and MAP, mean arterial blood pressure; NIHSS, National Institutes of Health Stroke Scales.